trending Market Intelligence /marketintelligence/en/news-insights/trending/yE4ulBHhzzyrrbNkMMX5DA2 content esgSubNav
In This List

Histogenics appoints EVP/COO

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Histogenics appoints EVP/COO

Histogenics Corp. named Stephen Kennedy as executive vice president and COO of the company.

Kennedy was promoted from his previous role as the company's chief technology officer.